Relapsed and Refractory Multiple Myeloma

Explore clinical trials studying Relapsed and Refractory Multiple Myeloma. Study availability and eligibility vary by location and protocol.

6 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Relapsed and Refractory Multiple Myeloma trial results

Recruiting

NCT05530421

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: University of Miami, Lennar Foundation Medical Center Coral Gables, Florida, United States

University of Miami, Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States

University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States

Completed

NCT03029234

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Beijing Chao Yang Hospital, Capital Medical University Beijing, Beijing Municipality, China

Peking University Third Hospital Beijing, Beijing Municipality, China

Fujian Medical University Union Hospital Fuzhou, Fujian, China

Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China

View all 17 locations

Completed

NCT03477643

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Hospital de Sant Joan de Déu Barcelona, Spain

Hospital Donostia-Donostia Ospitalea Donostia / San Sebastian, Spain

Hospital Universitario Virgen de Las Nieves Granada, Spain

Hospital General San Jorge - Huesca Huesca, Spain

View all 27 locations

Completed

NCT02144038

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(SC) Houston, Texas, United States

Seattle Cancer Care Alliance Oncology Dept Seattle, Washington, United States

University of Wisconsin / Paul P. Carbone Comp Cancer Center Dept of Onc. Madison, Wisconsin, United States

Novartis Investigative Site Prahran, Victoria, Australia

Completed

NCT00932698

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: H. Lee Moffitt Cancer Center Tampa, Florida, United States

Emory University Atlanta, Georgia, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

Active, Not Recruiting

NCT04155749

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Advanced Cellular Therapeutics Facility, DCAM 0800A Chicago, Illinois, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Froedtert Hospital/Medical College of Wisconsin Milwaukee, Wisconsin, United States